Member Info for nursesteve

The interesting thing for me will be the shareholders questions and answers. Might provide some titbits of information on how the trials are going?

What does that equate to ? About 74p a share? Probably a good move to take advantage of the recent rise in SP.

If someone was accumulating/ filling a large buy order it would make sense to ‘pause’ buying just to allow weak holders to sell and cause the price to drop back before they go again?

There might be a slight pullback but I’d expect us to finish the week near to 100p

Thanks for the correction Flippineck my mistake I was going by recall 😜.

Still something going on here and it could be preliminary efficacy 🤔

We don’t know what’s fuelling the recent increase in volume and share price. My speculation is that because it was the start of March that the first patient was dosed with the beast. At the time Chris said “ We look forward to RAPIDLY gathering data from patients in the FOCUS-01 trial, which is designed to determine the kinetics of payload release, pharmacodynamics, safety and PRELIMINARY EFFICACY of AVA6103." [bold to emphasis].

The tumour to plasma ratio increase shown in mice could very well be exceeded in clinic already, if this is so it would be hard to keep under wraps and could justify the sudden boost to the volume and price we are seeing since Thursday (are we missing the Thursday RNS? 😉).

Let’s hope for news soon to confirm what’s going on here. GLALTH’s

Maybe even by the middle of the week ? GL

LDA Concerted effort to rein in the share price?

“Something’s afoot” 7m traded on Thursday 5m Friday and 2m so far today. With sustained increases in price to year long highs. 🤔 all will be revealed soon. GLA

As has been said before “Every buy is a sell and every sell is a buy”. I do agree though it shows support to the share price at this level.

Might not be a rapid move to100p but the direction of travel is clear.

The chunky buys (e.g. 09:33:37 at 83p of 185,000 shares* 153.55k) demonstrating support with the volume traded over yesterday and today would seem to suggest a catalyst event is imminent and that it isn’t just PI’s buying in. GLA

The volume traded shows the demand for shares is there. Why now is open to speculation. IMHO we should certainly finish above 83p today and could significantly rerate upwards on any positive news from the trials, partnership deals, or FDA approval. Any of which could land anytime. GLALTH’s

6,811 shares at 0.8075 - feeling lucky to get in at that price.

Decent size buys after hours and throughout. This with the 6m days volume on no new news. Could indicate professional interest here? is it II or big Pharma?

We live in interesting times! Could be very interesting tomorrow!

Does seem like news is about to drop. Double the usual daily volume and up 13% 🤔

🤞for further rises. Certainly should rocket 🚀 on definitive news.

Volume increasing with some nice chunky buys going through. Knocking on 80p today.

By next week might even be ready to hit the 52 week high?

GLALTH’s

Thanks Blownitalready. Fabulous RNS. Increasing the possibility’s here. Licensing, Exclusive Partnership? Multiple Deals or TO ? First sniff of any will rerate the share price and could spark further interest. GLALTH’s

Be very hard to row back from this statement. A warning shot across the bows of big pharma. Wonder which companies produce those traditional drugs? Is Chris trying to get two big pharmaceutical companies to compete?

🚗 just a little bit longer kids!

Nearly there